Javascript must be enabled to continue!
Is furosemide a nephrotoxic for hospitalized patients?
View through CrossRef
Introduction: Acute kidney disease (AKI) is preventable in certain situations. Long-term and/or high dose furosemide may lead to acute kidney injury. Objectives: We aimed to find the risk of AKI among hospitalised patients who were exposed to furosemide. Patients and Methods: This is a retrospective cohort study of hospitalised patients who received furosemide therapy during the admission between 2019 and 2021. Exposure to furosemide was grouped into low dose (≤ 40 mg/d) or high dose (>40 mg/d) and short-term use (≤ 72 hours) or long-term use (>72 hours). Risk of acute kidney injury was calculated as odds ratios with a 95% confidence interval (CI). A P value <0.05 was considered statistically significant. Results: Of 314 patients who received furosemide intravenously or orally, 197 patients (62.7%) had acute kidney injury. Of 197 patients with acute kidney injury, 110 patients (55.9%) received the dosage of >40 mg/d and 121 patients (61.4%) were on furosemide for >7 days (odds ratios [ORs]: 5.46, 95% CI: 3.17 to 9.39, P≤0.001 and ORs: 7.72, 95% CI: 4.4 to 13.52, P≤0.001). In comparison, the 87 (44.1%) patients who received ≤40 mg/d of furosemide had a lower incidence of AKI (ORs: 0.25, 95% CI: 0.13 to 0.48, P≤0.001) and only 21 of the patients (10.6%) who received furosemide for < 7 days were found to have acute kidney injury (ORs: 0.08, 95% CI: 0.04 to 0.14, P≤0.001). The combined effect of high dose and long-term furosemide therapy is more consequential as we found that 100 (31.8%) patients who received furosemide >40 mg for >72 hours, 96 patients (30.6%) developed AKI (ORs: 26.8, 95% CI: 9.53 to 75.63, P≤0.001). Conclusion: Among hospitalised patients, exposure to high dose furosemide or prolonged use of furosemide is associated with AKI. The risk is more when high dose furosemide is administered for longer than 72 hours. Presence of underlying diabetes, hypertension, cardiac failure and chronic kidney disease, are also associated with furosemide -induced hospital-acquired acute kidney injury.
Maad Rayan Publishing Company
Title: Is furosemide a nephrotoxic for hospitalized patients?
Description:
Introduction: Acute kidney disease (AKI) is preventable in certain situations.
Long-term and/or high dose furosemide may lead to acute kidney injury.
Objectives: We aimed to find the risk of AKI among hospitalised patients who were exposed to furosemide.
Patients and Methods: This is a retrospective cohort study of hospitalised patients who received furosemide therapy during the admission between 2019 and 2021.
Exposure to furosemide was grouped into low dose (≤ 40 mg/d) or high dose (>40 mg/d) and short-term use (≤ 72 hours) or long-term use (>72 hours).
Risk of acute kidney injury was calculated as odds ratios with a 95% confidence interval (CI).
A P value <0.
05 was considered statistically significant.
Results: Of 314 patients who received furosemide intravenously or orally, 197 patients (62.
7%) had acute kidney injury.
Of 197 patients with acute kidney injury, 110 patients (55.
9%) received the dosage of >40 mg/d and 121 patients (61.
4%) were on furosemide for >7 days (odds ratios [ORs]: 5.
46, 95% CI: 3.
17 to 9.
39, P≤0.
001 and ORs: 7.
72, 95% CI: 4.
4 to 13.
52, P≤0.
001).
In comparison, the 87 (44.
1%) patients who received ≤40 mg/d of furosemide had a lower incidence of AKI (ORs: 0.
25, 95% CI: 0.
13 to 0.
48, P≤0.
001) and only 21 of the patients (10.
6%) who received furosemide for < 7 days were found to have acute kidney injury (ORs: 0.
08, 95% CI: 0.
04 to 0.
14, P≤0.
001).
The combined effect of high dose and long-term furosemide therapy is more consequential as we found that 100 (31.
8%) patients who received furosemide >40 mg for >72 hours, 96 patients (30.
6%) developed AKI (ORs: 26.
8, 95% CI: 9.
53 to 75.
63, P≤0.
001).
Conclusion: Among hospitalised patients, exposure to high dose furosemide or prolonged use of furosemide is associated with AKI.
The risk is more when high dose furosemide is administered for longer than 72 hours.
Presence of underlying diabetes, hypertension, cardiac failure and chronic kidney disease, are also associated with furosemide -induced hospital-acquired acute kidney injury.
Related Results
Furosemide in the management of acute kidney injury in the pediatric intensive care unit—retrospective cohort study
Furosemide in the management of acute kidney injury in the pediatric intensive care unit—retrospective cohort study
Abstract
Objective
To evaluate the effects of furosemide administration in critically ill children on the progression of acute kidney injury (AKI) a...
Influence of Mannitol and Furosemide, Alone and in Combination, on Brain Water Content after Fluid Percussion Injury
Influence of Mannitol and Furosemide, Alone and in Combination, on Brain Water Content after Fluid Percussion Injury
Background
Furosemide and mannitol are used to reduce intracranial pressure, but the impact of furosemide on edema of injured brain is unclear. The authors exam...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI
Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI
Abstract
Background
Perioperative acute kidney injury (AKI) caused by ischemia–reperfusion (IR) is a significant contribu...
#2823 Association between nephrotoxic drugs and the development of chronic kidney disease based on french real-world data
#2823 Association between nephrotoxic drugs and the development of chronic kidney disease based on french real-world data
Abstract
Background and Aims
Chronic kidney disease (CKD) is primarily associated with cardiovascular conditions such as ...
T211. COMPARISON OF REHOSPITALIZATION RATE IN INDIVIDUALS WITH SCHIZOPHRENIA CHANGED FROM PALIPERIDONE PALMITATE TO ORAL ANTIPSYCHOTICS
T211. COMPARISON OF REHOSPITALIZATION RATE IN INDIVIDUALS WITH SCHIZOPHRENIA CHANGED FROM PALIPERIDONE PALMITATE TO ORAL ANTIPSYCHOTICS
Abstract
Background
Long-acting antipsychotic therapy (LAT) may help effectively manage individuals with schizophrenia by optimi...
Effect of topical furosemide on sinonasal polyposis relapse after endoscopic sinus surgery
Effect of topical furosemide on sinonasal polyposis relapse after endoscopic sinus surgery
<p class="abstract"><strong>Background: </strong>Chronic rhinosinusitis with nasal polyposis (CRSwNP) relapse is commonly seen during follow up period after endos...
Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI.
Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI.
Abstract
Background: Perioperative Acute Kidney Injury (AKI) caused by Ischemia-Reperfusion (IR) is a significant contributor to mortality and morbidity after major surgery...

